A Pharmaceutical Titan's Bold Bet: Novartis Swallows Avidity in a $12 Billion Quest for Genetic Breakthroughs
The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic
Nektar Therapeutics Stock Soars Amid Intense Takeover Speculation
Bavarian Nordic's Future Intensifies: A Higher Bid Ignites Take-Private Battle
FDA Pumps the Brakes: Denali Therapeutics' Hunter Syndrome Drug Faces Extended Review
Truist Ignites Excitement for Rapport Therapeutics (RAPP) with New 'Buy' Rating and $21 Price Target
HCW Biologics Skyrockets 102% Overnight: What's Fueling the Biotech Boom?
Harbour BioMed Welcomes Dr. Yajie Li as New Chief Medical Officer
Rocket Soars: Why Rocket Pharmaceuticals Stock Just Exploded Over 15%!
CARsgen Therapeutics Unveils Stellar 2025 Interim Achievements: A Deep Dive into Innovation and Growth
Soligenix Soars: Groundbreaking Progress and Robust Financials Propel Q2 2025 Success